Drugs, Alcohol, Pregnancy, and the Child Series
Over one million children in this country per year are delivered to women who have used alcohol, tobacco, marijuana, or illicit drugs during pregnancy. This webinar series will explore the biological and environmental factors for mothers, children and families that impact the ultimate development of children affected by prenatal substance exposure and provide an overview of family- and school-based intervention strategies that can promote long-term growth and development of this high-risk population of children.
Addressing the Goodenough Syndrome through Building an Integrated System of Prevention and Early Intervention for Families and their Children Affected by Prenatal Substance Exposure
Wednesday, August 30, 2023
12:00 p.m.–1:30 p.m.
Webinar
No one system of care can fully provide the prevention services communities deserve nor the services children affected by prenatal substance exposure require. Thus, the most common scenario is one in which a community’s fragmented and siloed efforts result in the Goodenough Syndrome, denying children and families fully realized access to effective and appropriate levels of care. This session will bring together all topics discussed previously in this webinar series to present an evidence-based system of prevention and early intervention.
Learning objectives
At the completion of this session, participants will be able to:
This course is provided by Connecticut Hospital Association.
For more information please contact CHA Education Services on Phone # 203-294-7263 or by email address educationservices@chime.org.
Starts On
Registration Begins
Registration Ends